Atlas FDA

EXOGEN 2000+(TM) SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R))

FDA premarket approval P900009/S013 · decided 2001-09-04

Approval details

PMA number
P900009
Supplement
S013
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
EXOGEN 2000+(TM) SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R))
Generic name
Stimulator, ultrasound and muscle, for use other than applying therapeutic deep
Applicant
Bioventus, LLC
Date received
2001-04-30
Decision date
2001-09-04
Days to decision
127 days
Decision code
APPR
Product code
LPQ
Advisory committee
Orthopedic
Expedited review
No
Location
Durham, NC
Statement
APPROVAL FOR THE LOW INTENSITY ULTRASOUND FRACTURE TREATMENT SYSTEM-SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R)). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME EXOGEN 2000+(TM) SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R)) AND IS INDICATED FOR THE NON-INVASIVE TREATMENT OF ESTBLISHED NONUNIONS* EXLUDING SKULL AND VERTEBRA. IN ADDITION, THE EXOGEN 2000+(TM) OR SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R)) IS INDICATED FOR ACCELERATING THE TIME TO A HEALED FR

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
StimTrial Neuromodulation System (K243782)Bioventus, LLC2025-07-16
TalisMann Neuromodulation System (K243678)Bioventus, LLC2025-07-03
Allograft Delivery Device (OFAC-C) (K233368)Bioventus, LLC2024-06-25
SIGNAFUSE Bioactive Strip (SBS); SIGNAFUSE Putty (K233490)Bioventus, LLC2023-12-05
MCS Bone Graft (K162860)Bioventus, LLC2017-02-13